Clinical Trials Logo

Clinical Trial Summary

The study aim is to acquire human tissues to (a) understand the structure and organization of the human Enteric Nervous System; (b) perform a molecular transcriptomic profile of individual cells residing in the human gut; (c) study the turnover rates of individual cell types by Fluorescence-activated cell sorting-aided C14 dating of cells; and finally (d) culture the human gut-derived cells characterize the human adult enteric neural stem cell and study its potential for Neuro-glial differentiation. This study will advance our knowledge of the the cellular and molecular correlates of changes in the Enteric Nervous System that are associated with disorders of motility.


Clinical Trial Description

(i) To study the structure and organization of the human Enteric Nervous System by tissue clarification, immunofluorescence, and 2-photon and light-sheet microscopy. (ii) To find out the molecular signature that defines various gastrointestinal cells that include the neurons, glia, precursor cells within the Enteric Nervous System and cells associated with the Enteric Nervous System, such as Interstitial Cell of Cajal and macrophages in the human whole gut surgical resection and full thickness endoscopic resection-derived tissues using single cell RNA sequencing and analyses. (iii) To isolate these cells and study their proliferative and neurogenic potential in vitro and on transplantation into the gut tissue of immunodeficient mice. (iv) To time stamp and determine the age of Enteric Nervous System cells in adults and determine whether different enteric disease states alter the cycling times of these cells. (v) To use gut specimens derived from surgical resections and full thickness endoscopic resection-derived tissues for 1. Generating ex vivo preps to study and understand the electrophysiological properties of the gut wall and 2. Generating cultured ex vivo preps to understand the interaction between enteric extracellular matrix and cells of the Enteric Nervous System. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04880538
Study type Observational
Source Johns Hopkins University
Contact
Status Completed
Phase
Start date April 26, 2021
Completion date September 11, 2023

See also
  Status Clinical Trial Phase
Completed NCT01285570 - Ulimorelin Study of Efficacy and Safety (ULISES 007) Phase 3
Completed NCT01296620 - Ulimorelin Study of Efficacy and Safety (ULISES 008) Phase 3
Withdrawn NCT04872452 - Analysis of Cutaneous Nerve Biopsies in Gastrointestinal Motility Disorders N/A
Completed NCT01280344 - Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function Phase 2